The U.S. & Canada skin cancer dermatology market size is expected to reach USD 3,395.97 million By 2030, registering a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Technological advancements and increasing prevalence of skin cancer are anticipated to fuel the growth.
U.S. & Canada Skin Cancer Dermatology Market Report Highlights
- Skin biopsy is the most widely used test for skin cancer and thus, accounted for the largest market share in 2019
- Diagnostic imaging is anticipated to witness rapid growth over the forecast period due to the introduction of advanced imaging and non-invasive diagnostic techniques
- The 40-59 segment held the largest market share in 2019 while the 20-39 segment is anticipated to witness lucrative growth over the forecast period
- Teledermatology programs such as DermaGO, ACCESSDERM are anticipated to improve patient access in the U.S. and Canada
- Hospital OPD segment held a significant share of the U.S. and Canada skin cancer dermatology market in 2019 owing to the presence of public insurance systems is expected to enhance the patient influx in this setting
- Age and gender of the dermatologists significantly affect the type of practice, practice location and work hours.
- Some of the key market players are Firefly; SkinIO, Canfield Scientific, Inc., FotoFinder Systems, Inc., 3Gen, MetaOptima, Agilent Technologies, SkinVision, Speclipse, Inc., Skin Analytics.
Gain deeper insights on the market and receive your free copy with TOC now @: U.S. & Canada Skin Cancer Dermatology Market Report
Skin cancer is the most common cancer in the United States, with millions of cases diagnosed each year. the chances of successful treatment is high When skin cancer is found and treated early. The growing usage of smartphones and the development of smartphone compatible dermatoscopes are the factors anticipated to fuel the market growth. According to the Canadian Radio-television and Telecommunications Commission data, the percentage of Canadians using a smartphone increased from 73% in 2015 to 78% in 2017, thus indicating high potential for teledermatology in the country.
In addition, ongoing research activities for advancements in the dermatology field are anticipated to drive the growth of the market in U.S and Canada. For instance, according to the study published by Nature Journal, Deep Convolutional Neural Networks (CNN) classified the various skin cancers with a competence level comparable to a dermatologist, thus highlighting the potential of Artificial Intelligence (AI) in the field of dermatology.
Inappropriate use of ABCD criteria by Medical necessity auditors is one of the major concerns of dermatologists. For instance, some of the melanoma positive biopsies have been ruled as ‘medically unnecessary’ due to lack of medical documentation of ABCD or signs and symptoms. The ABCD tool was primarily designed for public education and not an important aspect of the physician’s note.
U.S. & Canada Skin Cancer Dermatology Market Insights By Test Type:
On the basis of test types, the market is further segmented into skin biopsy, dermatoscopy, diagnostic imaging, and lymph node biopsy. Skin biopsy is a procedure where a small amount of tissue is removed from the targeted area for examination under a microscope. The skin biopsy test type segment held the largest market share of 32.3%. The diagnostic imaging segment is anticipated to grow at the fastest CAGR over the forecast period due to the introduction of advanced non-invasive techniques, such as laser scanning confocal microscopy, optical coherence tomography, high-frequency ultrasound, terahertz pulsed imaging, magnetic resonance imaging, and photoacoustic microscopy, which have increased the accuracy of diagnosis.
Industry Analysis By Major Players:
Advancement in the field of skin cancer diagnosis and treatment is the key focus of competitors. The rising burden of skin cancer is expected to force major players to collaborate and discover advanced techniques for the efficient diagnosis of the disease. Some of the prominent players in the U.S. & Canada skin cancer dermatology market include:
- Firefly
- SkinIO
- Canfield Scientific, Inc.
- FotoFinder Systems, Inc.
- 3Gen
- MetaOptima
- Agilent Technologies
- SkinVision
For Any Questions or Inquire please visit @: https://www.grandviewresearch.com/industry-analysis/us-canada-skin-cancer-dermatology-market/request/rs5
U.S. & Canada Skin Cancer Dermatology Market Segmentation
Grand View Research has segmented the U.S. & Canada Skin Cancer Dermatology Market the basis of test type, facility type, and age group:
Test Type Outlook (Revenue, USD Million, 2018 – 2030)
- Skin Biopsy
- Dermatoscopy
- Diagnostic Imaging
- Lymph Node Biopsy
Age Group Outlook (Revenue, USD Million, 2018 – 2030)
- 0-19
- 20-39
- 40-59
- 60-64
- 65-74
- 75-84
- 85 & above
Facility Type Outlook (Revenue, USD Million, 2018 – 2030)
- Stand Alone Practices
- Multispecialty Clinics
- Dermatology Group
- Hospital OPD
- Others
Country Outlook (Revenue, USD Million, 2018 – 2030)
- U.S.
- Canada
List Of Key Players Of U.S. & Canada Skin Cancer Dermatology Market
- Firefly
- SkinIO
- Canfield Scientific, Inc.
- FotoFinder Systems, Inc.
- 3Gen
- MetaOptima
- Agilent Technologies
- SkinVision
- Speclipse, Inc.
- Skin Analytics
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/special-pricing/450277/rfsp2
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com